MCM3AP and posterior cortical atrophy: The results unveiled that the disease–free survival of MCM3AP-AS1 high expression group was shorter than that of MCM3AP-AS1 low expression group (Fig. 1c), suggesting that the dysfunction of MCM3AP-AS1 could take part in the progression of PCa.